COSCIENS Biopharma Inc. Common Stock (CSCI)

CSCI was delisted on the 3rd of September, 2025.

• Market cap: $8.64M
• Sector: Healthcare
• Industry: Biotechnology

About: Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.

Employees: 40